Obstructive sleep apnea SaaS platform
Biologix has raised $1.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Biologix's investors include Kortex Ventures, Eretz.bio, Hospital Israelita Albert Einstein.
Biologix is headquartered in São Paulo, Brazil.
Obstructive sleep apnea SaaS platform
Biologix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biologix — Funding & Investors." VCBacked, May 7, 2024, https://www.vcbacked.co/company/biologix. Accessed October 14, 2026.
VCBacked. (2024). Biologix — Funding & Investors. Retrieved October 14, 2026, from https://www.vcbacked.co/company/biologix
{{cite web |title=Biologix — Funding & Investors |url=https://www.vcbacked.co/company/biologix |website=VCBacked |access-date=October 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated